연구
교육
로그인
KR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
Skaggs School of Pharmacy and Pharmaceutical Sciences
Ralf J. Dirschinger has not added Biography.
If you are Ralf J. Dirschinger and would like to personalize this page please email our Author Liaison for assistance.
The protein tyrosine kinase inhibitor SU5614 inhibits FLT3 and induces growth arrest and apoptosis in AML-derived cell lines expressing a constitutively activated FLT3.
Blood Feb, 2003 | Pubmed ID: 12406902
Tbx20 regulates a genetic program essential to adult mouse cardiomyocyte function.
The Journal of clinical investigation Dec, 2011 | Pubmed ID: 22080862
Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia.
EMBO molecular medicine Dec, 2011 | Pubmed ID: 22174035
Recapitulating long-QT syndrome using induced pluripotent stem cell technology.
Pediatric cardiology Aug, 2012 | Pubmed ID: 22411718
Induced pluripotent stem cells in cardiovascular research.
Reviews of physiology, biochemistry and pharmacology , 2012 | Pubmed ID: 22447279
Modeling long-QT syndromes with iPS cells.
Journal of cardiovascular translational research Feb, 2013 | Pubmed ID: 23076501
Nocturnal Respiratory Rate Predicts Non-Sudden Cardiac Death in Survivors of Acute Myocardial Infarction.
Journal of the American College of Cardiology Feb, 2014 | Pubmed ID: 24613329
University of California, San Diego
Emilye Hiriart*,1,
Patrick van Vliet*,2,
Ralf J. Dirschinger2,
Sylvia M. Evans2,
Michel Puceat1
1INSERM UMR-910, Aix-Marseille University,
2Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego
개인 정보 보호
이용 약관
정책
연락처
사서에게 추천하기
JoVE 뉴스레터
JoVE Journal
연구 방법 컬렉션
JoVE Encyclopedia of Experiments
아카이브
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
교수 리소스 센터
저자
사서
액세스
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유